Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis
Caporali et.al.; Expert Rev Clin Immunol 2021 Jan;17(1):85-99